Advanced therapies boost UK’s life sciences ambitions - PharmaTimes CGT Catapult annual review shows sector’s impact on economy and patient access

#CGTCatapult #patientaccess #CellandGeneTherapyCatapult #advancedtherapies #lifesciences #lifescienceseconomy #cellandgenetherapy #cellandgenetherapyindustry #advancedtherapyclinicaltrials #CGTCatapultsupportedcompanies #pharmaindustry #healthcare #advancedtherapiessector
zurl.co/NISUD

UK project addresses capacity issue in CGT manufacturing A UK consortium has been set up to tackle a major issue in the development of cell and gene therapies (CGT) – a lack of manufacturing capacity.

#CGTmanufacturing #CellularOrigins #Constellation #cellandgenetherapymanufacturing #cellandgenetherapies #CGT #CGTproduction #CellandGeneTherapyCatapult #CGTCatapult #ResolutionTherapeutics #biomanufacturing #robotictechnologies #bioreactortechnology #Autolomous
pharmaphorum.com/news/uk-proj...

UK sees 70% increase in phase I advanced therapy clinical trials in 2024 - PharmaTimes Cell and Gene Therapy Catapult reveals significant growth in UK trials

#advancedtherapyclinicaltrials #CellandGeneTherapyCatapult #CGTCatapult #UKtrials #UK #clinicaltrials #phaseItrials #AdvancedTherapyMedicinalProductClinicalTrialsDatabase #ATMPClinicalTrialsDatabase #globaltrials #Europeantrials #Genetherapies #ATMPclinicaltrials
pharmatimes.com/news/uk-sees...